PARABDRUGS

Parabolic Drugs Limited has informed the Exchange regarding Board meeting held on February 11, 2021 for approval of un-audited financial results for quarter and nine month ended 31.12.2020

Parabolic Drugs Limited has informed the Exchange regarding Board meeting held on July 17, 2020.

Parabolic Drugs Limited has informed the Exchange regarding Board meeting held on August 14, 2018.

Parabolic Drugs Limited has informed the Exchange regarding Board meeting held on July 21, 2018.1. Considered and approved the change of registered/Corporate office of the company from S.C.O. 99-100, level third and fourth, Sector 17-B, Chandigarh to S.C.O. 186-187, 2nd floor, Sector 8C, Chandigarh.

Parabolic Drugs Limited has informed the Exchange regarding Board meeting held on May 29, 2018.

Parabolic Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on February 13, 2018.This is to inform you that the Board of Directors in its Meeting held on 13th February, 2018 and concluded at 05:10 p.m. :1. Approved the Unaudited Financial Results of the Company for the Quarter ended on 31st December, 2017.2. This is to inform you that Mr. Ashok Kumar Jindal, Chief Financial Officer and Compliance Officer of the Company has resigned from the service of the Company to pursue future career objectives.3. The Company is in the process of appointing a C

Parabolic Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on December 20, 2017.This is to inform you that the Board of Directors in its Meeting held on 20th December, 2017 and concluded at 03:15 p.m. :1. This is to inform you that Ms. Ishrat Gill, Company Secretary and Compliance Officer of the Company has resigned from the service of the Company to pursue future career objectives.2. The Company is in the process of appointing a Company Secretary who will act as the Compliance Officer of the Company. In the meantime, Mr. Ashok Kumar Jindal (Chief F

Parabolic Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on November 13, 2017.

Parabolic Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 21, 2017.1.Recommended the appointment of M/s. V.K. Jindal & Associates, Chartered Accountants as Statutory Auditors of the Company for a period of one year and the same would be presented for the approval of Shareholders at the forthcoming AGM. There office is located at S.C.O. 41, Second Level, Madhya Marg, Sector 20, Chandigarh. M/s. V.K. Jindal & Associates has vast experience in handling accounts auditing and other related matters.2.Re-appointed Mr. Harbans Lal as Internal Auditor of the Co

Parabolic Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on May 29, 2017.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors in its Meeting held on February 09, 2017 : (1) To take note that ICICI Bank, IDBI Bank, State Bank Of India, State Bank of Hyderabad, State Bank of Patiala and UCO Bank has assigned their debt in favor of JM Financial Asset Reconstruction Company Private Limited.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors in its Meeting held on November 12, 2016: Inter alia.1) To take note of the resignation of Chief Financial Officer, Mr. Sandeep Sharma of the company.

Parabolic Drugs Limited has informed the Exchange regarding outcome of meeting of the Board of Directors of the Company held on August 13, 2016.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors in its Meeting held on May 28, 2016: 1. Appointed R.K. Bhalla & Associates, Practicing Company Secretary as Secretarial Auditor of the Company

Parabolic Drugs Limited has informed the Exchange that the Board of Directors in its Meeting held on December 17, 2015: (1). Appointed Ms. Mallika Seth, as a Company Secretary of the Company.(2). Appointed Mr. Sanjeev Kumar, as an Independent Director on the Board of Directors of the Company.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors in its Meeting held on August 14, 2015:1. Approved the Performa & Annexure to be submitted with Cost Auditor report for the Financial Year 2014-15.2. Appointed DAV & Associates LLP, Chartered Accountants, as statutory auditors of the Company.

Parabolic Drugs Limited has informed the Exchange that the Board of Director in its Meeting held on February 14, 2015: 1. Appointed R.K. Bhalla & Associates, Practicing Company Secretary as Secretarial Auditor of the Company. 2. Took note of the Resignation of Mr. Balwan Bansal from the Board of Director of the Company.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors at its meeting held on August 14, 2014 has (1) Approved the Performa & Annexure to be submitted with Cost Auditor report for the Financial Year 2013-14.(2) Appointed Mr Jagit Singh Chahal as an Independent Director on the Board of Directors of the Company.(3) Took note of the resignation of Mr Nikhil Goel from the Board of Directors of the Company.(4) Reconstituted the Audit Committee, Nomination & Remuneration Committee and Stakeholders Relationship Committee of the Company.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 30, 2014, has:1. Recommended the reappointment of M/s. S. K. Bansal & Co., Chartered Accountants, Chandigarh, as Statutory Auditors, for the Financial Year 2014-15. 2. Approved the appointment of M/s. Anil Sharma & Co., Cost Accountants. Chandigarh, as Cost Auditors for the Financial Year 2014-15.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 14, 2014 has authorised the Committee of Directors (Share Allotment) to make allotment of 92,00,000 equity shares of the Company of Rs. 10/- each at a premium of Rs. 4.40/- per share, as already approved by the Members of the Company through Postal Ballot to the proposed allottees i.e. M/s. Kenam Education Services (P) Ltd., M/s. Parabolic Infrastructure (P) Ltd., M/s. PNG Trading (P) Ltd., M/s. Trackball Technology (P) Ltd., Mrs. Rama Gupta, Mr. Vineet Gupta and Mr. Pra

Parabolic Drugs Limited has informed the Exchange regarding the outcome of the Board Meeting of the Company held on November 14, 2013.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors of the Company in its meeting held on August 10, 2013 has: 1. Approved the resignation of Dr. Ram Kumar from the Directorship of the Company. 2. Approved the appointment of Mr. Balbir Singh Bhasin (a nominee of State Bank of India) on the Board of the Company. 3. Approved the reconstitution of Remuneration Committee and Investor's Grievance Committee of the Company. 4. Approved the re-appointment of Mr. Pranav Gupta as Managing Director and of Mr. Vineet Gupta as the Whole-Time Director of the Company.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors in its Meeting held on November 10, 2012: (a) Approved the resignation of Mr. Manmohan Lai Sarin from the Directorship of the Company. (b) Accorded its consent for making reference to the Corporate Debt Restructuring (CDR) Cell for Financial Restructuring of the Debts of the Company under CDR Mechanism formulated by Reserve Bank of India.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 13, 2011: (1) Approved the resignation of Mr. Anil Kumar from the post of Company Secretary w.e.f.May 23, 2011. (2) Approved the appointment of Mr. Vipin Gupta as Vice President & Company Secretary w.e.f August 05, 2011. (3) Appointed Mr. Vipin Gupta as the Compliance Officer in place of Mr. Anil Kumar. The Board, however, deferred the item on Agenda regarding issuance of Convertible Warrants on preferential basis.

Parabolic Drugs Limited has informed the Exchange that the Board of Directors in its meeting held on May 13, 2011: (1) Approved the reconstitution of Remuneration Committee and Investor Grievance Committee of the Company. (2) Recommended the amendment in the terms and conditions of the Prospectus dated June 24, 2010 of the Company.

Parabolic Drugs Limited has informed the Exchange that the Board of Director in its meeting held on February 01, 2011: (1) In accordance with the order of the Ministry of Corporate Affairs, the Company has appointed M/s Anil Sharma & Co., Cost Accountants as the Cost Auditor of the Company. (2) Approved the reconstitution of Share Transfer Committee of the Board. (3) Approved the appointment of Dr. Deepali Gupta, relative of the Directors as an employee of the Company.